Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CytoMed Therapeutics Limited GDTC

Set alert

Price alert · GDTC

All alert types
0.92 USD +0.02 +2.02%

At close · Oct 30

0.90 -0.02 -1.98%

After hours · Oct 30, 4:00 PM ET

Bid
0.90 × 3
Ask
0.92 × 1
0.8292 Day range 0.9188
0.723 52-week range 2.20
YTD
-31.43%
1 year
-57.27%
Open
0.8299
Prev close
0.9006
Mkt cap
10.97M
Vol
11.44K
Avg vol
19.11K
EPS
-0.23
P/E
0.00
Div yield
0.00%
More statistics
Low
0.8292
High
0.9188
Forward P/E
-15.80
Beta
0.00
Short ratio
7.54
Inst. own
0.04%
Dividend
0.00
Ex-div date
50-d avg
2.43
200-d avg
2.06
1y target
5.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for GDTC has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-1.10 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -5.1×
FY 2019: -35.9×FY 2020: -16.0×FY 2021: -18.0×FY 2022: -13.4×FY 2023: -16.6×FY 2024: -21.1×FY 2025: -5.1×
FY 2019 5y median -16.6× FY 2025
P/S 61.9×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 771×FY 2025: 61.9×
FY 2019 5y median 0.0× FY 2025
P/B 3.1×
FY 2019: 15.4×FY 2020: 65.3×FY 2021: 14.4×FY 2022: 72.0×FY 2023: 6.1×FY 2024: 6.0×FY 2025: 3.1×
FY 2019 5y median 6.1× FY 2025
P/FCF -4.6×
FY 2019: -16.4×FY 2020: -28.4×FY 2021: -16.3×FY 2022: -22.6×FY 2023: -19.1×FY 2024: -13.0×FY 2025: -4.6×
FY 2019 5y median -16.3× FY 2025
EV/EBITDA -5.2×
FY 2019: -70.4×FY 2020: -32.1×FY 2021: -24.4×FY 2022: -17.3×FY 2023: -16.3×FY 2024: -22.7×FY 2025: -5.2×
FY 2019 5y median -17.3× FY 2025
EV/Sales 56.9×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 706×FY 2025: 56.9×
FY 2019 5y median 0.0× FY 2025
FCF Yield -21.9%
FY 2019: -6.1%FY 2020: -3.5%FY 2021: -6.2%FY 2022: -4.4%FY 2023: -5.2%FY 2024: -7.7%FY 2025: -21.9%
FY 2019 5y median -6.2% FY 2025

Profitability

Gross Margin 79.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 75.4%FY 2025: 79.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin -1476.3%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -5175.3%FY 2025: -1476.3%
FY 2019 5y median 0.0% FY 2025
Net Margin -1227.1%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: -3621.1%FY 2025: -1227.1%
FY 2019 5y median 0.0% FY 2025
ROE -60.8%
FY 2019: -44.4%FY 2020: -407.1%FY 2021: -79.8%FY 2022: -531.0%FY 2023: -36.7%FY 2024: -28.1%FY 2025: -60.8%
FY 2019 5y median -60.8% FY 2025
ROIC -65.3%
FY 2019: -25.0%FY 2020: -38.3%FY 2021: -19.7%FY 2022: -48.5%FY 2023: -37.2%FY 2024: -37.8%FY 2025: -65.3%
FY 2019 5y median -37.8% FY 2025
ROA -49.8%
FY 2019: -29.2%FY 2020: -50.8%FY 2021: -34.0%FY 2022: -59.6%FY 2023: -33.3%FY 2024: -25.0%FY 2025: -49.8%
FY 2019 5y median -34.0% FY 2025

Growth (YoY)

Revenue 366.7%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 366.7%
FY 2019 FY 2025
Operating Income -33.1%
FY 2019: 0.0%FY 2020: -103.7%FY 2021: 12.9%FY 2022: -102.4%FY 2023: -86.4%FY 2024: 17.5%FY 2025: -33.1%
FY 2019 FY 2025
EPS (diluted) -54.5%
FY 2019: 0.0%FY 2020: -120.0%FY 2021: 9.1%FY 2022: -33.3%FY 2023: 2.5%FY 2024: 43.6%FY 2025: -54.5%
FY 2019 FY 2025
Free Cash Flow -7.1%
FY 2019: 0.0%FY 2020: 39.9%FY 2021: -109.8%FY 2022: 18.2%FY 2023: -91.4%FY 2024: -14.2%FY 2025: -7.1%
FY 2019 FY 2025

Financial Health

Current Ratio 5.2×
FY 2019: 1.5×FY 2020: 0.5×FY 2021: 1.1×FY 2022: 0.6×FY 2023: 14.1×FY 2024: 9.9×FY 2025: 5.2×
FY 2019 5y median 5.2× FY 2025
Quick Ratio 3.7×
FY 2019: 1.3×FY 2020: 0.5×FY 2021: 1.0×FY 2022: 0.5×FY 2023: 13.1×FY 2024: 8.5×FY 2025: 3.7×
FY 2019 5y median 3.7× FY 2025
Debt / Equity 0.1×
FY 2019: 0.3×FY 2020: 6.3×FY 2021: 1.3×FY 2022: 7.2×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.1×
FY 2019 5y median 0.1× FY 2025
Net Debt / EBITDA 0.5×
FY 2019: -0.7×FY 2020: -2.0×FY 2021: -0.5×FY 2022: -1.0×FY 2023: 2.3×FY 2024: 2.1×FY 2025: 0.5×
FY 2019 5y median 0.5× FY 2025
Interest Coverage -229×
FY 2019: 0.0×FY 2020: -12.6×FY 2021: -9.8×FY 2022: -18.7×FY 2023: -85.0×FY 2024: -177×FY 2025: -229×
FY 2019 5y median -85.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2019 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31